BioSpace News Archive

Agomab Therapeutics NV announced that it received Fast Track Designation from the U.S. Food and Drug Administration for AGMB-129 for the potential treatment of Fibrostenosing Crohn’s Disease.

Promore Pharma AB, reg. no. 556639-6809, held an extraordinary general meeting on Thursday, 5 October 2023.

Boehringer Ingelheim and Zealand Pharma A/S announced the initiation of three Phase III trials investigating survodutide for people living with overweight or obesity.

SpineThera, Inc., a privately held, clinical-stage pharmaceutical company focused on the development of SX600 announced United States Patent and Trademark Office has issued Patent No. 11,771,707 related to its micro-suspension platform technology.

InDex Pharmaceuticals Holding AB will attend the United European Gastroenterology Week, one of the world’s leading gastroenterology congresses.

Oculis Holding AG announced that the positive readout from Stage 1 of its Phase 3 DIAMOND trial of OCS-01 in patients with diabetic macular edema will be presented as a late-breaking abstract at the 23rd EURETINA Congress, taking place Thursday, October 5, 2023 through Sunday, October 8, 2023 in Amsterdam, the Netherlands.

Lightstone Ventures, ClavystBio, Leaps by Bayer, Polaris Partners, and the Polaris Innovation Fund, along with global life science company Evotec SE, today announced the launch of 65LAB to advance drug discovery and the creation of new therapeutics companies in Singapore.

Gerresheimer, innovative provider of systems and solutions and global partner for the pharma, biotech, and cosmetics industries, made progress toward another strong financial year and a sustained improvement in profitability in the first nine months of 2023.

Bayer AG has entered into an antibody discovery, option, and license agreement with Twist Bioscience Corporation, a company offering high-quality synthetic DNA using its silicon platform.

Fortress Biotech, Inc. today announced that Lindsay A. Rosenwald, M.D., Chairman, President and Chief Executive Officer, will present a corporate overview at the ROTH MKM 2023 Healthcare Opportunities Conference in New York City on Thursday, October 12, 2023.